Osteoporosis Market expected to rise | Companies – Shanghai JMT-Bio, Transcenta Holding, Celltrion, Sandoz, Enzene Biosciences, Fresenius Kabi, Gedeon Richter, expected to drive Osteoporosis Market

June 07 11:13 2023
Osteoporosis Market expected to rise | Companies - Shanghai JMT-Bio, Transcenta Holding, Celltrion, Sandoz, Enzene Biosciences, Fresenius Kabi, Gedeon Richter, expected to drive Osteoporosis Market
Osteoporosis Market
DelveInsight’s “Osteoporosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Osteoporosis, historical and forecasted epidemiology as well as the Osteoporosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Osteoporosis market growth is driven by factors like increase in the prevalence of Osteoporosis, investments in research and development, entry of emerging therapies during the study period 2019-2032.

The Osteoporosis market report also offers comprehensive insights into the Osteoporosis market size, share, Osteoporosis epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Osteoporosis market size growth forward. 

Some of the key highlights from the Osteoporosis Market Insights Report:

  • Several key pharmaceutical companies, including Shanghai JMT-Bio Inc., Transcenta Holding, Celltrion, Sandoz, Enzene Biosciences, Fresenius Kabi, Gedeon Richter, Samsung Bioepis, Alvotech, MAbxience, Shanghai Henlius Biotech, and others, are developing novel products to improve the Myelodysplastic Syndrome treatment outlook. 
  • The total Osteoporosis market size will include the market size of the potential upcoming therapies and current treatment regimens in the seven major markets.
  • As per DelveInsight analysis, the Osteoporosis market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Osteoporosis Market Landscape

Osteoporosis Overview 

Osteoporosis is a bone disease that develops when bone mineral density and bone mass decreases, or when the quality or structure of bone changes. This can lead to a decrease in bone strength that can increase the risk of fractures (broken bones). Osteoporosis is a “silent” disease because a person typically does not have symptoms, and may not even know that they have the disease until they break a bone. 

Osteoporosis is the major cause of fractures in postmenopausal women and in older men. Fractures can occur in any bone but happen most often in bones of the hip, vertebrae in the spine, and wrist. Osteoporosis affects women and men of all races and ethnic groups. Osteoporosis can occur at any age, although the risk for developing the disease increases as one gets older. Osteoporosis is most common in non-Hispanic white women and Asian women. Among men, osteoporosis is more common in non-Hispanic whites. 

Osteoporosis is called a “silent” disease” because there are typically no symptoms until a bone is broken or one or more vertebrae collapse (fracture). Symptoms of vertebral fracture include severe back pain, loss of height, or spine malformations such as a stooped or hunched posture (kyphosis).Bones affected by osteoporosis may become so fragile that fractures occur spontaneously or as the result of: Minor falls, such as a fall from standing height that would not normally cause a break in a healthy bone. 

Normal stresses such as bending, lifting, or even coughing. Osteoporosis occurs when too much bone mass is lost and changes occur in the structure of bone tissue. Certain risk factors may lead to the development of osteoporosis or can increase the likelihood that will develop the disease. Many people with osteoporosis have several risk factors, but others who develop osteoporosis may not have any specific risk factors. 

There are no clear physical signs of osteoporosis and it may not cause any problems for some time. If doctor thinks the patient might have osteoporosis, they may suggest to have a DEXA (dual energy x-ray absorptiometry) scan to measure the density of bones. The U.S. Preventive Services Task Force recommends screening for: Women over age 65, women of any age who have factors that increase the chance of developing osteoporosis. 

The goals for treating osteoporosis are to slow or stop bone loss and to prevent fractures. People who develop osteoporosis from another condition should work with their health care provider to identify and treat the underlying cause.

Do you know the treatment paradigms for different countries? Download our Osteoporosis Market Sample Report

Osteoporosis Epidemiology Segmentation 

DelveInsight’s Osteoporosis market report is prepared on the basis of an epidemiology model. It offers comprehensive insights to the Osteoporosis historical patient pools and forecasted Osteoporosis patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Osteoporosis Market report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:

  • Osteoporosis Prevalence 
  • Age-Specific Osteoporosis Prevalence 
  • Gender-Specific Osteoporosis Prevalence 
  • Diagnosed and Treatable Cases of Osteoporosis

Visit for more @ Osteoporosis Epidemiological Insights

Osteoporosis Treatment Market 

The Osteoporosis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Osteoporosis market trends by analyzing the impact of current Osteoporosis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Osteoporosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Osteoporosis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Osteoporosis market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Osteoporosis Companies working in the Osteoporosis market

Some of the key osteoporosis companies working in the osteoporosis market are Shanghai JMT-Bio Inc., Transcenta Holding, Celltrion, Sandoz, Enzene Biosciences, Fresenius Kabi, Gedeon Richter, Samsung Bioepis, Alvotech, MAbxience, Shanghai Henlius Biotech, and others.

Osteoporosis Key Companies

  • JMT 103: Shanghai JMT-Bio Inc.
  • TST-002: Transcenta Holding
  • CT-P41: Celltrion

For more information, visit Osteoporosis Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Osteoporosis Market Report:

  • 11 Years Forecast
  • 7MM Coverage 
  • Descriptive overview of Osteoporosis, causes, signs and symptoms, diagnosis, treatment
  • Comprehensive insight into Osteoporosis epidemiology in the 7MM
  • Osteoporosis marketed and emerging therapies 
  • Osteoporosis companies
  • Osteoporosis market drivers and barriers 

Key Questions Answered in the Osteoporosis Market Report 2032:

  • What was the Osteoporosis market share distribution in 2019, and how would it appear in 2032?
  • What is the total Osteoporosis market size and the market size by therapy across the 7MM for the study period (2019-32)?
  • What are the important findings from 7MM, and which country will have the greatest Osteoporosis market size from 2019-32?
  • During the study period (2019-2032), at what CAGR is the Osteoporosis market projected to expand at 7MM?

Table of Contents:

1 Osteoporosis Market Key Comprehensive Insights 

2 Osteoporosis Market Report Introduction

3 Competitive Intelligence Analysis for Osteoporosis

4 Osteoporosis Market Analysis Overview at a Glance

5 Executive Summary of Osteoporosis

6 Osteoporosis Epidemiology and Market Methodology

7 Osteoporosis Epidemiology and Patient Population

8 Osteoporosis Patient Journey

9 Osteoporosis Treatment Algorithm, Osteoporosis Current Treatment, and Medical Practices

10 Key Endpoints in Osteoporosis Clinical Trials

11 Osteoporosis Marketed Therapies 

12 Osteoporosis Emerging Therapies

13 Osteoporosis: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Osteoporosis

16 Osteoporosis Market Key Opinion Leaders Reviews

18 Osteoporosis Market Drivers

19 Osteoporosis Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Osteoporosis Epidemiology 2032

DelveInsight’s “Osteoporosis – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Osteoporosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Osteoporosis Pipeline 2023

“Osteoporosis Pipeline Insights, 2023” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Osteoporosis market. A detailed picture of the Osteoporosis pipeline landscape is provided, which includes the disease overview and Osteoporosis treatment guidelines. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/